SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950136-07-008573
Filing Date
2007-12-31
Accepted
2007-12-31 10:26:54
Documents
8
Period of Report
2008-01-31
Effectiveness Date
2007-12-31

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT file1.htm DEF 14A 838780
2 ebox.gif GRAPHIC 58
3 xbox.gif GRAPHIC 63
4 spacer.gif GRAPHIC 43
5 proxycard-2.jpg GRAPHIC 62641
6 proxycard-1.jpg GRAPHIC 153866
7 html_301085pblogo.jpg GRAPHIC 40348
8 html_301085chart01.jpg GRAPHIC 36867
  Complete submission text file 0000950136-07-008573.txt   1246286
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33357 | Film No.: 071333472
SIC: 2836 Biological Products, (No Diagnostic Substances)